NEW YORK (GenomeWeb News) – Myriad Genetics today expanded its patient financial assistance program to include some who are underinsured.

Under the expanded program, Myriad will offer financial assistance to certain underinsured patients so that they have to pay out-of-pocket costs of no more than $375. To be eligible, patients must have private insurance, meet their insurers' coverage criteria for testing, and have a household income that does not exceed 200 percent of the Federal financial poverty level, Myriad said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.

Wired writes that CRISPR could change the world — in many imaginative ways — and whether it will be for the better is still in the air.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.